In postmenopausal women with T2D, osteoglycin levels are associated with duration of diabetes, decreased aBMD and presence of vertebral fractures but not N-terminal cross-linked telopeptide of type-I collagen (NTX), osteocalcin (OC), fasting glucose or HbA1c (15). This evidence concerns the gene OGN and type 2 diabetes mellitus.